Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04022499 · ClinicalTrials.gov registry record · NA
Presessions for the National Diabetes Prevention Program
A NA study, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- NA
- Development phase
- 483
- Enrollment target
NCT04022499: Completed NA study, sponsored by Denver Health and Hospital Authority.
NCT04022499 is a NA study that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 483 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04022499, a NA study, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- NA
- Development phase
- 483 participants
- Enrollment target
Study Summary
The National Diabetes Prevention Program (NDPP) is a widely available, evidence-based intervention that promotes weight loss to prevent type 2 diabetes; however, participant attendance is problematic and leads to suboptimal weight loss, especially among Hispanic, non-Hispanic black, and low-income non-Hispanic white participants. An innovative pre-session enhancement to the NDPP (Pre-NDPP) showed successful results upon initial application in a diverse and predominately low-income population, with doubled attendance and weight loss outcomes as compared to previous NDPP participants who did not receive a pre-session. If Pre-NDPP is shown to be successful upon more rigorous study, it can be widely adopted by NDPP providers across the country to help reduce diabetes prevalence and related health disparities.
Primary Outcome
Percent body weight change from baseline to 12 months
Interventions
- BEHAVIORAL Presessions
- BEHAVIORAL National Diabetes Prevention Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 483 participants |
| Start Date | 2019-08-06 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
What the finished NCT04022499 record still lists
NCT04022499 is an interventional study that assigns participants to a tested intervention. The registered 483 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 2 interventions - of which Presessions is the first listed.
NCT04022499 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04022499 about?
NCT04022499 is a clinical study titled "Presessions for the National Diabetes Prevention Program". The National Diabetes Prevention Program (NDPP) is a widely available, evidence-based intervention that promotes weight loss to prevent type 2 diabetes; however, participant attendance is problematic and leads to suboptimal weight loss, especially among Hispanic, non-Hispanic black, and low-income n...
What is the current status of trial NCT04022499?
This trial is currently completed. It is a NA study. The enrollment target is 483 participants. The study started on 2019-08-06. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT04022499?
The interventions under investigation include: Presessions (BEHAVIORAL), National Diabetes Prevention Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04022499?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04022499's enrollment target sits among peer trials
483 216th of 2000 higher than 1,785 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI